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Abstract 
Background: Plasmodium falciparum dramatically alters the morphology and properties of the infected red blood 
cells (iRBCs). A large group of exported proteins participate in these parasite-host interactions occurring at the iRBC 
membrane skeleton. SURFIN4.2 is one of iRBC surface protein that belongs to surface-associated interspersed protein 
(SURFIN) family. Although the intracellular tryptophan-rich domain (WRD) was proposed to be important for the 
translocation of SURFINs from Maurer’s clefts to iRBC surface, the molecular basis of this observation has yet to be 
defined. The WRDs of P. falciparum SURFIN proteins and their orthologous Plasmodium vivax subtelomeric transmem-
brane proteins (PvSTPs) show homology to the intracellular regions of PfEMP1 and Pf332, both of which are involved 
in RBC membrane skeleton interactions, and contribute to malaria pathology.
Methods: Two transfected lines expressing recombinant SURFINs (NTC-GFP and NTC-4.2WRD2-GFP) of the 3D7 
sequence were generated by transfection in P. falciparum. In vitro binding assays were performed by using recombi-
nant WRDs of SURFIN4.2/PvSTP2 and inside-out vesicles (IOVs). The interactions between the recombinant WRDs of 
SURFIN4.2/PvSTP2 with actin and spectrin were evaluated by the actin spin down assay and an enzyme-linked immu-
nosorbent assay based binding assays, respectively.
Results: The recombinant SURFINs (NTC-4.2WRD2-GFP), in which the second WRD from SURFIN4.2 was added back 
to NTC-GFP, show diffused pattern of fluorescence in the iRBC cytosol. Furthermore, WRDs of SURFIN4.2/PvSTP2 
were found to directly interact with the IOVs of RBC, with binding affinities ranging from 0.26 to 0.68 μM, values that 
are comparable to other reported parasite proteins that bind to the RBC membrane skeleton. Further experiments 
revealed that the second WRD of SURFIN4.2 bound to F-actin (Kd = 5.16 μM) and spectrin (Kd = 0.51 μM).
Conclusions: Because PfEMP1 and Pf332 also bind to actin and/or spectrin, the authors propose that the interaction 
between WRD and RBC membrane skeleton might be a common feature of WRD-containing proteins and may be 
important for the translocation of these proteins from Maurer’s clefts to the iRBC surface. The findings suggest a con-
served mechanism of host-parasite interactions and targeting this interaction may disrupt the iRBC surface exposure 
of Plasmodium virulence-related proteins.
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Background
In spite of extensive control efforts, malaria continues to 
be a major health problem worldwide, causing approxi-
mately 438,000 deaths in 2015. In Africa alone, the death 
toll reached 292,000 among children under five years old 
[1]. The malignant tertian parasite Plasmodium falcipa-
rum accounts for the majority of fatal malaria infections. 
Severe pathologies such as organ failure and dysfunc-
tion, cerebral malaria, and placental malaria are most 
often associated with sequestration of the infected red 
blood cells (iRBCs) into the deep microcapillaries of 
these organs by adhering to endothelial cells. Cytoad-
herence is mediated by parasite proteins exported to the 
iRBC membrane. These proteins are first transported 
across the parasite plasma membrane and the parasito-
phorous vacuole membrane (PVM). Then they are sorted 
and translocated through the Maurer’s clefts and finally 
inserted into the iRBC membrane [2, 3]. Maurer’s clefts 
are membranous structures involved in sorting and 
translocating parasite proteins to the iRBC membrane [4, 
5]. These extensive modifications of the iRBC dramati-
cally alter its morphology, antigenicity and functions, 
including the appearance of knob protrusions on the 
iRBC surface, increased rigidity and poor deformabil-
ity of iRBC, and increased adhesiveness of the iRBC to 
the endothelium [4, 6, 7]. Some exported proteins such 
as PfEMP1, PfEMP3, MESA, Pf332, PfSBP1, KAHRP1, 
and RESA interact with RBC membrane skeleton [7–13]. 
In addition, PfEMP1 family proteins encoded by the var 
gene family bind to host factors such as CD36, ICAM-
I, and CSA, mediating cytoadherence of the iRBCs and 
leading to severe pathologies.
Among P. falciparum proteins that contain tryptophan-
rich residues are the SURFIN family proteins. SURFIN4.2 
is one of the iRBC-exported proteins and is encoded by 
a small family of surface-associated interspersed (surf) 
genes consisting of 10 members in the P. falciparum 
genome [14]. Plasmodium falciparum SURFINs form 
one clade with the Plasmodium vivax subtelomeric 
transmembrane proteins (PvSTPs) [15]. The intracellu-
lar tryptophan-rich domains (WRDs) of SURFIN/PvSTP 
are related to the sequences of the intracellular regions of 
PfEMP1 and Pf332 [14]. SURFIN4.2 localizes to Maurer’s 
clefts and has been reported to be trafficked to the sur-
face of the iRBC together with RIFIN and PfEMP1 [14]. 
Thus, SURFIN/PvSTP proteins are potential immune tar-
gets and malaria vaccine candidates [16, 17]. For another 
member SURFIN4.1, the N-terminal 50 amino acids, 
transmembrane domain, and adjacent intracellular region 
contain sufficient information for recruiting a recombi-
nant protein into the classical ER/Golgi secretory path-
way, and for efficient translocation across the PVM to the 
Maurer’s clefts [18]. The mechanism by which SURFIN 
proteins are anchored into the iRBC membrane has yet 
to be elucidated, but recombinant SURFIN4.2 possessing 
the intracellular WRD can be cleaved by surface treat-
ment of iRBC with proteinase K, suggesting the WRD of 
SURFIN4.2 may be responsible for transport of the pro-
tein from Maurer’s clefts to the iRBC membrane [19]. 
Interestingly, intracellular region of Pf332 that is homolo-
gous to the SURFIN WRD is found to associate with actin 
filaments of RBC membrane skeleton [12]. In the case 
of PfEMP1, the intracellular VARC region (also known 
as the acidic terminal sequence, ATS) having homology 
with WRD binds to host spectrin-actin [4, 20, 21]. Thus, 
this study aimed to identify host RBC proteins that may 
associate with SURFIN4.2 WRD. This could provide an 
important insight into the molecular basis of trafficking 
of SURFIN proteins from Maurer’s cleft to iRBC surface. 
This study revealed binding of WRDs of SURFIN4.2 and 
PvSTP2 to RBC membrane skeleton proteins, and inter-
actions between the second WRD of SURFIN4.2 with 
actin and spectrin.
Methods
Construction of plasmids for Plasmodium falciparum 
transfection
Plasmids used to transfect P. falciparum were pre-
pared based on the Multisite Gateway System (Thermo 
Scientific, USA). The template plasmids pENT12-
SURFIN4.12Myc-N-T-Cyt and pENT12-SURFIN4.12Myc-N-T-Cyt-StuI 
were generated using the Q5® Site-Directed Mutagenesis 
Kit (NEB) [22] based on the initially generated pENT12-
SURFIN4.1N-T-Cyt plasmids (Primer list; Additional file  1) 
[18]. For P. falciparum transfection, the region encod-
ing WRD2 of SURFIN4.2 was amplified by PCR with 
primers listed in Additional file  1. PCR fragments were 
analysed by electrophoresis on a 1.2% agarose gels, and 
purified by using TaKaRa MiniBEST DNA Fragment 
Purification Kit Ver.4.0 (Takara, Japan). The purified 
PCR product was ligated into the StuI site of pENT12-
SURFIN4.12Myc-N-T-Cyt-StuI plasmid to generate the pENT12-
SURFIN4.12Myc-N-T-Cyt-4.2WRD2 plasmid. All constructs 
were verified by restriction digestion and sequencing. 
Ultimately, pENT12-SURFIN4.12Myc-N-T-Cyt and pENT12-
SURFIN4.12Myc-N-T-Cyt-4.2WRD2 plasmids were recombined 
with the destination plasmid pCHD43-II (modified based 
on pCHD-3/4 plasmid [23]) with pENT41-pfHsp86-
5′UTR and pENT23-GFPm2 using the Gateway Multisite 
LR recombination reaction according to the manufactur-
er’s instruction.
Preparation of recombinant proteins
For recombinant protein expression in E. coli, specific 
primers (Additional file  1) were designed with refer-
ence to the surf4.2 and pvstp2 nucleotide sequences and 
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used to PCR amplify DNA fragments encoding WRDs 
of SURFIN4.2 and Pf332 from P. falciparum 3D7 [amino 
acid positions: SURFIN4.2 WRD1 (959–1201); SURFIN4.2 
WRD2 (1349–1567); SURFIN4.2 WRD2-1 (1349–1499); 
SURFIN4.2 WRD3 (1729–1990); SURFIN4.2 CRD (1–197); 
Pf332 WRD (5565–5825)] and WRD of PvSTP2 from P. 
vivax Sal-I cDNA (amino acids 592–825). Approximately 
2 mg recombinant SURFIN4.2WRD2 (amino acids 1349–
1567) tagged with His tag expressed in a yeast expression 
system were obtained from the Gene Create Company 
(Wuhan, China). A DNA fragment encoding a region of 
KAHRP protein (amino acid positions 320–451), which 
contain 72 amino acid spectrin-binding fragments 
(amino acid positions 370–441, [24]) was also amplified 
from 3D7 cDNA as a positive control for spectrin bind-
ing assays (primers listed in Additional file 1). For surf4.2, 
pvstp2, and kahrp320–451, PCR products were cloned into 
the pBADR-DEST49 vector using the Gateway clon-
ing technology (Thermo Scientific, USA). The inserts 
were verified by sequencing and plasmids were desig-
nated as pBADR-SURFIN4.2WRD1 (SURFIN4.2WRD1), pBADR-
SURFIN4.2WRD2 (SURFIN4.2WRD2), pBADR-SURFIN4.2WRD2-1 
(SURFIN4.2WRD2-1), pBADR-SURFIN4.2WRD3 (SURFIN4.2WRD3), 
pBADR-SURFIN4.2CRD (SURFIN4.2CRD), pBADR-PvSTP2WRD 
(PvSTP2WRD), and pBADR-KAHRP320–451 (KAHRP320–451). 
For Pf332 (positive control), the PCR product was 
cloned into pET-32a (+) to generate pET32a-Pf332WRD 
(Pf332WRD). Recombinant WRDs were expressed in 
E. coli BL21 Rosetta-gamiB (DE3) after induction 
with 0.001% l-arabinose or 1  mM isopropyl β-d-1-
thiogalactopyranoside at 20  °C for 16  h. The bacterial 
cells were then collected by centrifugation (8000×g for 
10 min, 4 °C), resuspended, and lysed by BugBuster Mas-
ter Mix (Merck). After 20 cycles of sonication (10 s pulses 
with 3  s intervals between each cycle), the lysates were 
collected by centrifugation (11,000×g, 4 °C) and superna-
tants were purified on -IDA-Sefinose TM Resin (Sangon 
Biotech, China) according to the manufacturer’s protocol. 
The recombinant WRDs were dialyzed against phosphate 
buffed saline (PBS) at 4 °C for 72 h with buffer changing 
every 24  h, and concentrated by using Amicon® Ultra-
0.5 (Millipore, USA). The concentrations of recombinant 
proteins were determined by using the TaKaRa BCA 
Protein Assay Kit (Takara, Japan). The molecular weight 
(MW) of each recombinant WRDs were estimated using 
ExPASy Bioinformatics Resource Portal (http://ca.expasy.
org/tools/pi_tool.html [25]). All His-tagged recombi-
nant proteins were clarified by ultracentrifugation at 
150,000×g for 30 min before use.
Parasite culture and transfection
The P. falciparum 3D7 line was cultured in vitro in RPMI 
medium supplemented with 5% human serum plus 0.25% 
Albumax I according to the standard method as previ-
ously described [26]. Transfection was performed as 
described [18] and parasites were selected with WR99210 
(a gift from D. Jacobus, Jacobus Pharmaceutical Co. Inc., 
USA) first at a concentration of 5 nM and then at 10 nM 
when parasites reappeared.
Indirect immunofluorescence assay (IFA)
Thin smears of P. falciparum-iRBCs on glass slides were 
briefly dried and fixed with 4% paraformaldehyde and 
0.005% glutaraldehyde in PBS for 15  min at room tem-
perature. After rinsing with 50  mM glycine, the slides 
were blocked with 5% of skim milk in PBS for 30 min at 
37 °C. The slides were first incubated with mouse mono-
clonal anti-GFP (Roche, Switzerland) and rabbit anti-
EXP2 antiserum at 1:1000 dilutions or rabbit anti-SBP1 
at 1:500 dilutions or rat anti-PfEMP1 1:500 dilutions at 
37 °C for 1 h. Then, the slides were incubated with Alexa-
Fluor 488-conjugated goat anti-mouse or Alexa-Fluor 
594-conjugated goat anti-rabbit or Alexa-Fluor 594-con-
jugated goat anti-rat antibodies at 1:2000 (Thermo Scien-
tific, USA) at 37  °C for 30 min. DAPI (Sigma) was used 
at 1 μg/ml as a counterstain of parasite nuclei. ProLong® 
Diamond Antifade Mountant (Thermo Scientific, USA) 
was applied onto the slide to reduce quenching under the 
UV light. The slides were viewed with a Nikon ECLIPSE 
80i microscope. The signal intensity of immunofluores-
cence in P. falciparum transfectants was measured with 
ImageJ software (1.44p; http://rsbweb.nih.gov/ij/).
In vitro binding assays
Inside-out-vesicles (IOVs) of normal human RBCs were 
prepared using a previously described method [12]. 
In vitro binding assays using IOVs were conducted by an 
enzyme-linked immunosorbent assay (ELISA) format. 
Briefly, prepared IOVs diluted in an incubation buffer (IB; 
138 mM NaCl, 5 mM KCl, 6 mM Na2HPO4, 5 mM glu-
cose, pH 9.0) were coated onto 96-well plates (Dynatech 
Laboratories Inc., USA) overnight at 4 °C. The plate was 
washed then blocked with 5% (w/v) bovine serum albu-
min (BSA) in PBS for 1 h at room temperature. Serially 
diluted His-tagged recombinant WRD proteins, includ-
ing Pf332WRD, SURFIN4.2WRD1, SURFIN4.2WRD2, SURFIN4.2WRD3, 
and PvSTP2WRD (0.25–10 μM) were added to the IOVs-
coated plates and incubated overnight at 4 °C. His-tagged 
protein from the empty vector pET-32a (+) was used as 
a negative control (detailed protein sequence informa-
tion of His-tagged unrelated protein is shown in Addi-
tional file  2). Plates were washed five times, followed 
by the detection of the recombinant proteins with the 
HRP-conjugated anti-His tag antibody (Abcam, USA). 
Colour development was done by adding 100 μl of TMB 
microwell peroxidase substrate. After reaction at room 
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temperature for 5 min, 50 μl of 2 mM H2SO4 were added 
to each well to terminate the reaction, and absorbance at 
450 nm was measured using an ELISA microplate reader. 
For internal control, BSA was used instead of IOVs. A 
saturation of binding curve was constructed from the 
optical density (OD) values of the representative bind-
ing assay after subtraction of the signal obtained from the 
BSA control. The dissociation constant (Kd) was deter-
mined by regression analysis of the binding curves.
Actin co‑sedimentation assays
The specificity and affinity of the interaction between 
SURFIN4.2WRD2-His and F-actin were detected by using the 
Actin Binding Protein Spin-Down Assay kit (Cytoskele-
ton, USA). Briefly, 250 µl of G-actin (Cytoskeleton, USA) 
at 1  mg/ml was polymerized to F-actin by adding 25  µl 
of actin polymerization buffer (500  mM KCl, 20  mM 
MgCl2, and 10 mM ATP) into the G-actin solution for 1 h 
at room temperature. F-actin (7 μM) was incubated with 
SURFIN4.2WRD2-His protein (titrated from 12.5 to 0.0 μM), 
the His-tagged protein from the empty vector as a nega-
tive control (7.0 μM), and the positive control Pf332WRD 
(4.2  μM) at room temperature for 30  min, followed by 
ultracentrifugation at 150,000×g for 1.5 h at 24 °C using 
an ultracentrifuge (Himac CS150GXL; Hitachi, Japan). 
The resulting pellet was resuspended in 50  μl of 1× 
Pierce™ Lane Marker Reducing Sample Buffer (Thermo 
Scientific, USA) to the original sample volume, resolved 
by 10% SDS-PAGE, transferred to PVDF for Western blot 
detection using either HRP-conjugated anti-6× His tag 
antibody, rabbit anti-actin antibody (Sigma, China), or 
mouse anti-actin antibody (clone 1A4, Thermo Scientific, 
USA). The Western blot was analysed by densitometry 
using the ImageJ software. After subtracting the non-
specific binding, a binding curve using the densitometric 
data was plotted and the dissociation constant (Kd) and 
Bmax were determined by nonlinear regression analy-
sis (one-site specific binding model) using GraphPad 
Prism 6 software. The specificity of interaction between 
SURFIN4.2WRD2-1-His, SURFIN4.2CRD-His, and SURFIN4.2WRD2-
His and F-actin was also evaluated by using the actin spin 
down assay following the same protocol.
In vitro binding assay with spectrin
His-tagged recombinant SURFIN4.2WRD2 was diluted in 
PBS and binding assays were performed in a similar man-
ner to the IOV binding assays. Briefly, 100 ng of purified 
human spectrin (Sigma) was coated on a 96-well plate at 
4 °C overnight. After washing the plate and blocking with 
5% BSA at room temperature for 1 h, actin (6 µM), BSA 
(6 µM), and recombinant SURFIN4.2WRD2-His (6 µM) were 
added to the spectrin-coated plate and incubated over-
night at 4  °C. After washing with PBS three times, the 
bound proteins were stripped off from the plates with a 
SDS sample buffer, and analysed by Western blot using 
a monoclonal mouse 6× His tag antibody (Thermo Sci-
entific, USA), rabbit anti-actin antibody. Spectrin dimer 
and BSA were evaluated by Coomassie Brilliant Blue 
staining. In a parallel study, the bound proteins, including 
KAHRP320−451 (positive control), His (negative control), 
and recombinant SURFIN4.2WRD2-His were processed for 
quantification using an ELISA-based in vitro binding for-
mat as described above.
Results
Effect of the SURFIN4.2 WRD2 on the recombinant 
mini‑SURFIN protein localization in P. falciparum‑iRBC
The intracellular regions of PfEMP1 and Pf332 are known 
to interact with the RBC membrane skeleton com-
ponents, including actin and spectrin. The alignment 
between WRDs of SURFIN4.2/PvSTP2 and intracellular 
regions of PfEMP1 and Pf332 show positionally con-
served amino acids in RBC membrane skeleton binding 
regions (Additional file 3). Furthermore, based on the fact 
that the mini-SURFIN4.1 consisting of the N-terminus, 
the transmembrane region, and a short cytoplasmic tail 
of SURFIN4.1 fused with GFP at C-terminus was able to 
be trafficked to Maurer’s clefts, two plasmids were gen-
erated expressing mini-SURFIN4.1 fused with or without 
SURFIN4.2 WRD2, which share high similarity between 
SURFIN4.1 and SURFIN4.2 proteins (NTC-4.2WRD2-
GFP or NTC-GFP, respectively; Additional file  4). IFA 
with the PVM marker EXP2 revealed that NTC-GFP 
was exported beyond the PVM into infected RBC (iRBC) 
cytosol, and the signals showed a dotted pattern, which 
co-localized with the Maurer’s cleft marker SBP1, sug-
gesting Maurer’s cleft localization (Fig. 1a). The dominant 
fluorescence signals were detected in parasite cytosol 
and Maurer’s cleft, as shown in plot profiles by Image J 
analysis. However, NTC-4.2WRD2-GFP produced sig-
nals beyond the PVM with a diffused localization pattern 
in the iRBCs, which only partially co-localized with the 
Maurer’s cleft marker SBP1 and with PfEMP1, suggesting 
that it was likely transported beyond Maurer’s clefts and 
to the RBC cytosol or membrane (Fig. 1b), a result that is 
consistent with previous reports [6, 19].
Recombinant WRD2 of SURFIN4.2 is associated with the RBC 
IOVs
To evaluate the interaction of WRD2 of SURFIN4.2 with 
RBC membrane skeleton, binding assays were performed 
using the recombinant His-tagged SURFIN4.2 WRD2 
protein (SURFIN4.2WRD2-His) and IOVs prepared from nor-
mal human RBC (Fig. 2a). A His-tagged unrelated protein 
(His-tag control protein) was used as a negative control. 
SDS-PAGE of the IOVs followed by Coomassie Brilliant 
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Blue staining confirmed the presence of the major RBC 
membrane skeleton proteins, including spectrin, protein 
4.1 and actin (Additional file 5). SURFIN4.2WRD2-His bound 
to the IOVs in a dose-dependent manner and saturated 
at ~10 µM of SURFIN4.2WRD2-His, whereas only a trace level 
of His-tag control protein was detected under identical 
conditions (Fig. 2b), suggesting that the binding between 
SURFIN4.2WRD2-His and IOVs was specific. To characterize 
the affinities of SURFIN4.2WRD2-His with IOVs, Scatchard 
analysis was performed. The results showed that the Kd 
and Bmax values of the affinities of SURFIN4.2WRD2-His to 
IOV were 0.58 ± 0.02 µM and 0.44 ± 0.03 µM, respec-
tively (Fig. 2c). Together, these interaction assays suggest 
that the WRD2 of SURFIN4.2 binds to the RBC mem-
brane skeleton.
Other WRDs of P. falciparum SURFIN4.2 and P. vivax PvSTP2 
also bind to the RBC IOVs
Potential interactions ofWRD1 and WRD3 of SURFIN4.2 
and WRD of PvSTP2, a P. vivax SURFIN-ortholog, 
with the RBC IOVs were further examined. The puri-
fied recombinant SURFIN4.2WRD1-His, SURFIN4.2WRD3-His, 
Fig. 1 Localization and signal intensity comparison of mini-SURFIN4.1, NTC-GFP and NTC-4.2WRD2-GFP, in P. falciparum-iRBC. a Co-localization 
of NTC-GFP with the PVM marker EXP2 and Maurer’s cleft marker SBP1. Upper panel Schematic drawing of NTC-GFP. Lower panels Representative 
fluorescence images showing the co-localization of NTC-GFP with EXP2 and SBP1. b Co-localization of NTC-4.2WRD2-GFP with EXP2, SBP1 and 
PfEMP1. Upper panel Schematic drawing of NTC-4.2WRD2-GFP. Lower panels Representative fluorescence images showing the co-localization of 
NTC-4.2WRD2-GFP with EXP2, SBP1 and PfEMP1. The differential interference contrast images merged with nucleus stained with DAPI (DIC + Nuc), 
fluorescence images with mouse anti-GFP antibody (anti-GFP), PVM location with rabbit anti-EXP2 antibody (anti-EXP2) or Maurer’s cleft location 
with rabbit anti-SBP1 antibody (anti-SBP1), or rat anti-PfEMP1 antibody (anti-PfEMP1), and merged image are shown. Bar 5 μm. Scale refers to the 
residue number of recombinant SURFIN4.1 protein. Plot profiles of signal intensities evaluated by ImageJ software are shown by a grey scale on the 
right side of each immunofluorescence panel, along with the Western blot data for recombinant SURFINs. The bands at the predicted size for the 
recombinant NTC-GFP and NTC-4.2WRD2-GFP are marked with arrowheads. Parasite/PV indicates parasite cytosol or parasitophorous vacuole
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PvSTP2WRD-His, and Pf332WRD-His (positive control) 
proteins were examined by the IOV interaction assays 
(Fig.  3a). ELISA and Scatchard analyses showed that 
the SURFIN4.2WRD1-His, SURFIN4.2WRD3-His, and PvSTP-
2WRD-His all bound to the RBC IOVs in a dose-depend-
ent manner (Fig.  3b; Additional file  6) with the Kd and 
Bmax values of the interactions being 0.68  ±  0.16 and 
0.46 ± 0.00, 0.53 ± 0.10 and 0.59 ± 0.03, and 0.26 ± 0.03 
and 0.25 ± 0.01 µM, respectively. Kd and Bmax values of 
positive control Pf332WRD-His were 0.10  ±  0.02 and 
1.92 ± 0.04 µM, respectively, and those of negative con-
trol were −0.01 ± 0.20 and 0.22 ± 0.04 µM, respectively.
Interaction of His‑tagged recombinant SURFIN4.2
WRD2 
with F‑actin
To determine whether actin in the RBC membrane skel-
eton is responsible for the binding to the recombinant 
SURFIN4.2WRD2-His, a polymerized F-actin co-sedimen-
tation assay was carried out. SURFIN4.2WRD2-His was 
detected in the pellet fraction, whereas His tag alone was 
not co-precipitated, indicating that the SURFIN4.2WRD2-
His binding to F-actin was specific (Fig.  4a). These 
results were further proved by using SURFIN4.2WRD2-His 
expressed in a yeast expression system in the actin spin 
down assay, where the majority of SURFIN4.2WRD2-His was 
detected in the pellet fraction (Additional file  7). How-
ever, the recombinant protein that contains a shortened 
fragment of SURFIN4.2 WRD2 region, SURFIN4.2WRD2-1-
His, was not enriched in the pellet, indicating that essen-
tial F-actin binding motifs may exist in the WRD2 region 
of SURFIN4.2 (Additional file  7). Interestingly, testing 
the cysteine-rich domain (CRD) of SURFIN4.2, originally 
selected as a negative control, also detected interaction 
between SURFIN4.2CRD-His with F-actin (Additional file 7). 
Fig. 2 Binding assays with inside-out vesicles (IOVs). a Expression and purification of recombinant SURFIN4.2
WRD2-His. The Coomassie Brilliant Blue 
staining (left) and Western blot analysis (middle) of the total E. coli lysates of the uninduced (Pre), induced, and purified culture of recombinant 
SURFIN4.2
WRD2-His (calculated MW, 46.5 kDa). Right panel shows a Western blot for the bound, washed, and eluted fractions of the His tag alone 
(20.4 kDa). The bands at the predicted size for the recombinant protein were marked with arrowheads. b A saturation binding curve using ELISA-
based protein interaction analysis. The dissociation constant (Kd) was determined to be 0.58 ± 0.02 μM. c Scatchard plot of SURFIN4.2WRD2-His and IOVs 
interaction. Bmax = 0.44 ± 0.03 μM
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The binding of the positive control Pf332WRD-His to 
F-actin was also confirmed (Fig. 4a). The binding affinity 
of SURFIN4.2WRD2-His to F-actin was determined by incu-
bating F-actin with Pf332WRD-His, His-tag control pro-
tein, or serially diluted SURFIN4.2WRD2-His. Western blot of 
a representative experiment for both the supernatant and 
pellet fractions is shown in Fig. 4b. Nonlinear regression 
analysis showed that the binding of SURFIN4.2WRD2-His to 
F-actin was specific and saturable. Notably, the Kd and 
Bmax values of SURFIN4.2WRD2-His binding to F-actin were 
5.16  ±  0.29 and 1.92  ±  0.15  μM, respectively (Fig.  4c). 




Finally, the study examined whether the recombinant 
SURFIN4.2WRD2-His interacts with another component of 
the RBC skeleton, spectrin. An in  vitro binding assay 
with recombinant human spectrin followed by West-
ern blot analysis detected the positive control actin and 
SURFIN4.2WRD2-His from the spectrin-bound fraction, 
whereas only a residual level of BSA (as the negative con-
trol) was detected (Fig.  5a). Scatchard analysis of the 
ELISA-based spectrin-binding assay of SURFIN4.2WRD2-
His by using the His-tagged KAHRP spectrin-binding 
fragment as a positive control (amino acids 320–451, 
KAHRP320–451-His; Additional file 8) and His only protein 
as a negative control revealed that the Kd and Bmax values of 
SURFIN4.2WRD2-His and spectrin interaction were 0.51 ± 0.38 
and 1.34 ± 0.13 µM, respectively (Fig. 5b). Taken together, 
these data indicate that the WRD2 of SURFIN4.2 was able 
to bind to spectrin with modest affinity.
Discussion
The human RBCs are enucleated, terminally differenti-
ated cells, and packed with hemoglobin that is responsi-
ble for oxygen and carbon dioxide transportation in the 
circulatory system. RBCs contain a membrane bound 
skeleton network primarily comprised of spectrin, actin, 
and protein 4.1, which make the RBCs highly deformable 
to pass through the capillaries/reticuloendothelial system 
without fragmentation. However, after malaria parasite 
invasion, the morphology and functions of iRBCs are 
dramatically modified, a process that contributes to the 
disease pathology. Malaria parasites as ‘master renova-
tors’ of their host cells achieve these modifications by 
exporting hundreds of proteins into the iRBC cytosol 
[27]. Some of these exported proteins are located to the 
surface of iRBC, such as the cytoadhesins PfEMP1, STE-
VOR, and RIFIN, and others including RESA, MESA, 
and PfEMP3, which become associated with the RBC 
membrane skeleton [7, 10, 13, 28–31].
Furthermore, some proteins reside in the Mau-
rer’s cleft, which acts as a sorting depot for proteins en 
route to the surface of iRBC, including SBP1, REX1, 
and MAHRP1, which are responsible for PfEMP1 to be 
inserted into the plasma membrane of iRBC [10, 32, 33]. 
Extensive studies in protein trafficking have identified 
the Plasmodium exported element (PEXEL) in numer-
ous parasite exported proteins. However, an even prob-
ably larger group of Plasmodium parasites also exported 
is PEXEL-negative proteins (PNEPs), including PfEMP1, 
SURFIN family, and some Maurer’s cleft dotting pro-
teins, which typically contain an internal transmembrane 
domain that functions as an ER sorting signal, and an 
essential N-terminal signal responsible for further locali-
zation to the iRBC surface or remaining in the cytosol to 
help remodeling the iRBCs [18, 34–37]. The trafficking 
mechanism of most of the PNEPs including SURFIN is 
not fully understood.
Fig. 3 Interactions of recombinant WRDs of SURFIN4.2 and PvSTP2 
with IOVs. a His-tagged recombinant WRD proteins were purified 
using the Ni-IDA-Sefinose TM Resin and analysed by Western blot. 
S Soluble fraction, P pellet fraction. Arrowheads indicate bands of 
His-tagged recombinant PvSTP2WRD (calculated MW, 46.5 kDa), 
SURFIN4.2
WRD1 (48.9 kDa), SURFIN4.2
WRD3 (51.0 kDa), and Pf332WRD 
(46.5 kDa). Soluble fractions of each recombinant protein were used 
for the in vitro interaction assays with membrane skeleton of RBC. 
b Saturation curves of the binding of recombinant WRD proteins to 
IOVs were measured by ELISA-based protein interaction analysis
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As one of the variant surface antigens (VSAs), surfin/
pvstp gene family possesses 10 members in P. falciparum 
and two members in P. vivax; some were also detected 
in the genomes of Plasmodium ovale curtisi and Plas-
modium ovale wallikeri [14, 16, 38, 39]. Furthermore, 
previous hierarchical clustering analysis identified two 
surfin/pvstp genes in Plasmodium gallinaceum (PgSurf1 
and PgSurf2), indicating that SURFINs are also con-
served outside the human malaria parasites [40]. Mul-
tiple sequence alignment revealed that SURFIN/PvSTP 
proteins, P. falciparum PfEMP1 and Pf332, and Plas-
modium knowlesi SICAvar are interrelated through a 
Fig. 4 Binding of the His-tagged recombinant SURFIN4.2
WRD2 to F-actin. a The supernatant and pellet fractions of SURFIN4.2
WRD2-His (SURFIN4.2
WRD2), 
Pf332WRD-His (Pf332WRD), and His-tag control protein after F-actin co-sedimentation assay were analysed by Western blot with anti-His tag or anti-
actin antibodies. Arrows indicate recombinant protein bands with the expected size. S Supernatant fraction, P pellet fraction. b Western blot of the 
supernatant (left) and pellet (right) fractions after F-actin co-sedimentation with serially diluted SURFIN4.2
WRD2-His, control His-tagged control protein, 
and Pf332WRD-His are shown. Because the signal of the Pf332WRD detected in the pellet fraction was saturated, the intensity of this lane was reduced. 
c Saturation curves of the binding of SURFIN4.2
WRD2-His to F-actin based on the F-actin co-sedimentation assays
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modular and structurally conserved intracellular WRD 
[14, 40]. PfEMP1 WRD binds to host spectrin-actin with 
high affinity (Kd =  0.04 µM), and also interacts electro-
statically with four linear sequence motifs in KAHRP to 
form a fuzzy complex and to govern the phenomena of 
knob formation and cytoadherence of iRBC [4, 20, 21]. 
Furthermore, a 260-residue sequence within the WRD of 
Pf332 specifically interacts with F-actin (Kd =  0.60  μM, 
[12]). In the current study, WRD2 shared the most simi-
larity between two known exported SURFINs, SURFIN4.1 
and SURFIN4.2. Previous data have shown that recombi-
nant SURFIN4.2 containing WRDs were mainly detected 
in Triton X-100 insoluble fractions, compared to the one 
without WRD, and also exhibited a unique localization 
pattern in the iRBC cytosol, implying a direct interaction 
of these SURFIN4.2 with the RBC membrane [6]. Consist-
ently, by fusing the conserved WRD2 of SURFIN4.2 with 
the minimum Maurer’s cleft targeting motifs present in 
SURFIN4.1 [18], the recombinant NTC-4.2WRD2 also 
was targeted to the iRBC cytosol. Sequence conserva-
tion among WRDs suggested that WRD serves as a 
domain responsible for the binding to RBC membrane 
skeleton in most SURFIN/PvSTP proteins. To test this, 
in  vitro binding experiments were performed by using 
other WRDs from SURFIN4.2 and PvSTP2 proteins with 
IOVs. In almost all cases, direct SURFIN/PvSTP WRD 
binding was observed with Kd values ranging from 0.26 
to 0.68  µM. These modest binding values are of similar 
magnitude to the affinities of those observed in other 
Plasmodium proteins that are associated with RBC mem-
brane skeleton, such as Pf332 (Kd = 0.40 µM) [7, 12, 29].
The potential binding between WRD2 of SURFIN4.2 and 
actin (an RBC membrane component) is implied from 
several clues. A previous report identified a fragment of 
260 residues within the WRD of Pf332, which can bind 
to F-actin in a specific and saturable manner [12]. Pair-
wise sequence alignment revealed high sequence similar-
ity between Pf332 and SURFIN/PvSTP proteins in this 
region [40], which makes actin the strongest candidate 
that interact with WRD2 of SURFIN4.2. This study tested 
the direct interaction between WRD2 of SURFIN4.2 and 
F-actin, which indeed confirmed such an interaction, 
albeit the interaction was relatively weak (Kd = 5.16 μM), 
and this interaction was abolished by further trunca-
tion of the recombinant protein. This value was more 
than eight folds higher than that detected for Pf332 in 
the previous study (Kd = 0.6 μM) [12] and other known 
parasite-host interacting proteins, including PfCor-
N (Kd =  0.96  μM) and PfAldolase (Kd =  0.37  μM) [32, 
41]. It is noteworthy that the Kd values of all examined 
WRDs of SURFIN4.2 and PvSTP2 with IOVs are similar 
and significantly higher than that of WRD of Pf332 and 
IOVs. Thus, the Kd value for the WRD2 of SURFIN4.2–F-
actin interaction likely reflects the nature of the WRD2 
of SURFIN4.2. It is tempting to speculate that the weak 
affinity of P. falciparum SURFIN WRD may be the driv-
ing force of the multiplication of this domain in the 
SURFIN family proteins in P. falciparum, which need to 
compete with other P. falciparum-specific proteins that 
also interact with actin and/or spectrin, such as PfEMP1, 
Pf332, and PfEMP3. However, it is also possible that the 
adjacent residues of the examined WRDs could enhance 
protein–protein interaction with RBC membrane skel-
eton, as has been reported for MESA interaction with 
protein 4.1 [42]. These possibilities need to be evalu-
ated in the future. Interestingly, this study also identified 
interactions between the CRD of SURFIN4.2 and F-actin. 
Fig. 5 Binding of SURFIN4.2
WRD2-His to spectrin. a Immunoblots from 
the spectrin binding assay. F-actin (positive control), SURFIN4.2
WRD2-His, 
and BSA (negative control) were stripped from spectrin-coated wells, 
separated by SDS-PAGE, and stained by Coomassie Brilliant Blue (left 
panel). Immunoblot was performed with anti-His tag antibody and 
anti-actin antibody (right panel). Expected sizes of SURFIN4.2
WRD2-His, 
actin, spectrin dimer, and BSA were ~46.5, 43, 250, and 66.4 kDa, 
respectively (indicated by the arrowheads). b The binding affinity of 
SURFIN4.2
WRD2-His, KAHRP320–451-His, and His protein with spectrin. A 
binding saturation curve was constructed based on values obtained 
by the ELISA-based assay using serially diluted SURFIN4.2
WRD2-His and 
KAHRP320–451-His. An unrelated His protein was used as the negative 
control
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However, this interaction may not be physiological since 
CRD and host F-actin are predicted to be located in dif-
ferent cellular compartments.
Another major component of the RBC membrane skel-
eton is spectrin, which is a flexible rod-like protein that 
predominantly exists as an α2β2 tetramer, and interacts 
with actin, protein 4.1, and ankyrin to form a network 
[43]. Several trafficked proteins to the RBC membrane 
interact with spectrin. Among them, RESA binds to the 
β chain of spectrin with a 108 amino acid fragment (resi-
dues 663–770), and stabilizes the spectrin tetramer and 
enhances resistance of the iRBCs to both mechanical and 
thermal degradation [29]. The spectrin-binding domain 
in KAHRP has been localized to a 72-residue region (res-
idues 370–441), which is critical in membrane localiza-
tion of KAHRP [24]. In the current study, the WRD2 of 
SURFIN4.2 also was found to interact with spectrin with 
the Kd value of 0.51 μM, which is comparable to that of 
RESA (0.88 μM) and PfEMP3 (0.38 μM) [29, 31]. Since no 
conserved motifs have been identified between SURFIN/
PvSTP WRD and these previously identified spectrin-
binding parasite proteins, it is possible that binding sites 
of spectrin for these parasite proteins might be differ-
ent. The binding motifs in both spectrin and WRD2 
of SURFIN4.2, and the functional role of this binding to 
spectrin remain to be further evaluated. Interestingly, the 
data presented here showed that the WRD2 of SURFIN4.2 
was able to interact with both actin and spectrin. This 
is not an exception; a 14-residue fragment of PfEMP3 
also has dual binding abilities to both spectrin and actin 
[7]. This dual binding ability detected in SURFIN4.2 and 
PfEMP3 may increase the affinity of these proteins for the 
iRBC membrane skeleton.
Conclusions
This study identified SURFIN/PvSTP as a novel RBC 
membrane skeleton-binding protein family. The WRD2 
of SURFIN4.2 was capable of interacting with both RBC 
membrane skeleton proteins actin and spectrin. These 
results imply that the WRDs of SURFIN/PvSTP proteins 
might be functionally conserved, and have evolved with 
the RBC skeleton interaction during protein trafficking 
process. Future studies will focus on pinpointing the key 
region(s) of the WRD2 of SURFIN4.2 which is involved in 
binding to actin and spectrin, as well as the role for these 
interactions. Understanding the parasite-host interac-
tion mechanism, especially with regard to the surface 
expressed parasite antigens that are potentially involved 
in pathologic consequences, may facilitate the develop-
ment of methods that interfere with these processes.
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